Zoetis EVP awarded RSUs and stock options

Zoetis Inc. Executive Vice President Jamie Brannan received new equity awards.

Rhea-AI Filing Summary

Zoetis Inc. Executive Vice President Jamie Brannan received new equity awards. On February 18, 2026, Brannan was granted 5,399 restricted stock units and 21,361 stock options, each at an exercise price of $0.00 per unit or option.

Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of the RSUs and one-third of the options will vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. Following these grants, Brannan directly holds RSUs and multiple option positions reflecting prior annual awards under the company’s equity and incentive plans.

Insider Trade Summary

Grant/Award: 26,760 shares

Grant/Award 8 txns

Insider Brannan Jamie

Role Executive Vice President

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	5,399	$0.00	$0.00
Grant/Award	Stock Option	21,361	$0.00	$0.00
holding	Restricted Stock Unit	--	--	--
holding	Restricted Stock Unit	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Restricted Stock Unit — 9,542.0741 contracts for 4,143.0741 underlying shares (Direct); Stock Option — 52,237 contracts for 30,876 underlying shares (Direct)

Footnotes (15)

1. F1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. F2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
3. F3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. F4. Not applicable.
5. F5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
6. F6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. F7. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
8. F8. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
9. F9. Each option expires on the tenth anniversary of the date of grant.
10. F10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
11. F11. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
12. F12. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
13. F13. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
14. F14. 2,764 options granted February 13, 2018 at an exercise price of $73.24 per option; 1,465 options granted February 12, 2019 at an exercise price of $87.51 per option; 732 options granted February 11, 2020 at an exercise price of $144.03 per option; 869 options granted February 10, 2021 at an exercise price of $160.62; and 1,111 options granted February 8, 2022 at an exercise price of $201.30 per option.
15. F15. Each option vested on the third anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Zoetis (ZTS) grant to Executive Vice President Jamie Brannan?

Zoetis granted Jamie Brannan 5,399 restricted stock units and 21,361 stock options on February 18, 2026. These awards were issued under the Zoetis equity and incentive plans as part of his executive compensation package, aligning his interests with long-term shareholder value.

How do the new RSU awards for Zoetis (ZTS) EVP Jamie Brannan vest?

The 5,399 restricted stock units vest in three equal installments on the first, second and third anniversaries of the February 18, 2026 grant date. Vesting is conditioned on Brannan’s continued service and may accelerate upon specific events described in the award terms.

What are the key terms of Jamie Brannan’s new Zoetis (ZTS) stock option grant?

Brannan received 21,361 stock options that vest one-third on each of the first, second and third anniversaries of the February 18, 2026 grant date. Each option has a ten-year term from grant, consistent with the Zoetis equity and incentive plan documentation.

Do Jamie Brannan’s Zoetis (ZTS) RSUs convert into common stock?

Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. Shares are delivered as units vest and settle, meaning the underlying stock is issued over time as vesting conditions tied to continued service are satisfied.

What existing equity holdings for Zoetis (ZTS) EVP Jamie Brannan are shown in this Form 4?

The filing updates Brannan’s direct holdings in RSUs and stock options from earlier grants. It lists outstanding RSU balances and option positions from prior annual awards, reflecting their remaining totals after previous vesting while not indicating any sales or disposals.

Under which plan were Jamie Brannan’s new Zoetis (ZTS) awards granted?

The RSUs and stock options were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. This plan provides stock-based compensation to executives, linking a portion of their pay to the company’s performance and long-term share price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 08:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brannan Jamie

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	(2)	02/18/2026		A		5,399		(3)	(4)	Common Stock	5,399	$0	5,399	D
Restricted Stock Unit(1)	(2)							(5)	(4)	Common Stock	3,614.0741		3,614.0741	D
Restricted Stock Unit(1)	(2)							(6)	(4)	Common Stock	529		529	D
Stock Option(7)	$129.13	02/18/2026		A		21,361		(8)	(9)	Common Stock	21,361	$0	21,361	D
Stock Option(7)	$156.64							(10)	(9)	Common Stock	13,877		13,877	D
Stock Option(7)	$196.14							(11)	(9)	Common Stock	5,955		5,955	D
Stock Option(7)	$162.07							(12)	(9)	Common Stock	4,103		4,103	D
Stock Option(13)	(14)							(15)	(9)	Common Stock	6,941		6,941(14)	D

Explanation of Responses:

1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

4. Not applicable.

5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

7. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

8. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.

9. Each option expires on the tenth anniversary of the date of grant.

10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.

11. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.

12. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.

13. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

14. 2,764 options granted February 13, 2018 at an exercise price of $73.24 per option; 1,465 options granted February 12, 2019 at an exercise price of $87.51 per option; 732 options granted February 11, 2020 at an exercise price of $144.03 per option; 869 options granted February 10, 2021 at an exercise price of $160.62; and 1,111 options granted February 8, 2022 at an exercise price of $201.30 per option.

15. Each option vested on the third anniversary of the date of grant.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.